Protective effect of polyethylene glycol (PEG) 3350 on a cisplatin-induced rat model of neuropathy

Basit Öğe Kaydı
dc.contributor.authorGönüllü, Edip
dc.contributor.authorDağıstan, Gözde
dc.contributor.authorErdoğan, Mümin Alper
dc.contributor.authorErbaş, Oytun
dc.date.accessioned2023-03-22T19:47:34Z
dc.date.available2023-03-22T19:47:34Z
dc.date.issued2022
dc.departmentBelirleneceken_US
dc.description.abstractBackground and Objective: Peripheral neuropathy is the most important side effect, leading to a decrease in the dose of cisplatin or its complete cessation in the early period. For this purpose, the study aimed to investigate the therapeutic potential of PEG in cisplatin-induced neuropathy and to measure the levels of MDA, GSH, IL-6 and TNF-alpha, which are key markers of lipid peroxidation and antioxidant capacity. Materials and Methods: Cisplatin was given to 16 rats twice a week for 4 weeks at a rate of 2.5 mg/kg/day. Cisplatin-treated rats were split into two groups. For 4 weeks, the rats in Group 1 (n = 8) received 1 mL/kg/day of 0.9% NaCl intraperitoneally, while the rats in Group 2 received 30 mg/kg/day of PEG. The control group consisted of the eight surviving rat specimens. The motor abilities of all the animals were assessed after the research. Blood samples were collected for the measurement of plasma lipid peroxidation malondialdehyde (MDA), Tumour Necrosis Factor (TNF-alpha), glutathione (GSH) and IL-6 levels. Results: Electromyography findings revealed that compound muscle action potential (CMAP) amplitude was significantly higher in the cisplatin-PEG group than in the cisplatin-saline group. Also, cisplatin-PEG treated group showed significantly lower TNF-alpha, MDA and IL-6 levels and hig her GSH levels than the cisplatin-saline group (p<0.01, p<0.001). In addition, while the CMAP latency was decreased in the PEG-treated group, the CMAP amplitude was increased and a significant improvement was observed in the Inclined test scores. Besides, histological examinations showed an increase in axon diameter and NGF expression with PEG treatment. Conclusion: This study demonstrated that PEG exerts protective activity against cisplatin-induced neurotoxicity by increasing endogenous antioxidants and reducing lipid peroxidation and inflammation.en_US
dc.identifier.doi10.3923/ijp.2022.1359.1365
dc.identifier.endpage1365en_US
dc.identifier.issn1811-7775
dc.identifier.issn1812-5700
dc.identifier.issue7en_US
dc.identifier.startpage1359en_US
dc.identifier.urihttps://doi.org/10.3923/ijp.2022.1359.1365
dc.identifier.urihttps://hdl.handle.net/20.500.14034/771
dc.identifier.volume18en_US
dc.identifier.wosWOS:000871581300003en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAsian Network Scientific Information-Ansineten_US
dc.relation.journalInternational Journal Of Pharmacologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCisplatinen_US
dc.subjectneuropathyen_US
dc.subjectpolyethylene glycolen_US
dc.subjectPEGen_US
dc.subjectelectromyographyen_US
dc.subjectoxidative damageen_US
dc.subjectinflammationen_US
dc.subjectOxidative Stressen_US
dc.subjectNeurotoxicityen_US
dc.titleProtective effect of polyethylene glycol (PEG) 3350 on a cisplatin-induced rat model of neuropathyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
edip gönüllü.pdf
Boyut:
833.98 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin / Full text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Cerrahi Tıp Bilimleri Bölümü Koleksiyonu